These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 24253250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B, Clagett B, Robinson J, Lederman MM, McComsey GA.
    J Acquir Immune Defic Syndr; 2015 Apr 01; 68(4):396-404. PubMed ID: 25514794
    [Abstract] [Full Text] [Related]

  • 3. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
    Longenecker CT, Hileman CO, Funderburg NT, McComsey GA.
    Clin Infect Dis; 2014 Oct 15; 59(8):1148-56. PubMed ID: 25015912
    [Abstract] [Full Text] [Related]

  • 4. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
    Dirajlal-Fargo S, Kinley B, Jiang Y, Longenecker CT, Hileman CO, Debanne S, McComsey GA.
    AIDS; 2015 Jan 28; 29(3):313-21. PubMed ID: 25686680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
    Calza L, Vanino E, Salvadori C, Manfredi R, Colangeli V, Cascavilla A, Di Bari MA, Motta R, Viale P.
    HIV Clin Trials; 2014 Jan 28; 15(1):1-13. PubMed ID: 24518210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.
    Erlandson KM, Jiang Y, Debanne SM, McComsey GA.
    Clin Infect Dis; 2015 Nov 15; 61(10):1566-72. PubMed ID: 26157049
    [Abstract] [Full Text] [Related]

  • 15. Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.
    Erlandson KM, Jiang Y, Debanne SM, McComsey GA.
    AIDS; 2015 Jan 14; 29(2):175-82. PubMed ID: 25396266
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Rosuvastatin for the treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy. Preliminary experience].
    Bottaro EG, Caravello O, Scapellato PG, Stambulian M, Vidal GI, Loggia V, Scapellato JL, Thompson F, Cassetti I.
    Enferm Infecc Microbiol Clin; 2008 Jan 14; 26(6):325-9. PubMed ID: 18588813
    [Abstract] [Full Text] [Related]

  • 19. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
    Hileman CO, Tangpricha V, Sattar A, McComsey GA.
    J Acquir Immune Defic Syndr; 2017 Apr 15; 74(5):539-547. PubMed ID: 28045766
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.